2-(4-(1-carboxyethyl) benzyl) adipic acid and preparation method thereof

By preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid in the production of loxoprofen sodium, the problem of this impurity affecting the quality of the drug is solved, and the acquisition of high-purity products and drug products are achieved. Scientific evaluation of quality improves the safety and production control of drugs.

CN119019250APending Publication Date: 2024-11-26BEIJING MINGZE ZHONGHE PHARM RES CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411114426.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The ring-opening impurity 2-(4-(1-carboxyethyl)benzyl)adipic acid produced in the production of loxoprofen sodium affects the quality and safety of use, and lacks effective synthesis methods for quality control.

Method used

Provide a preparation method of 2-(4-(1-carboxyethyl)benzyl)adipic acid, by reacting 2-methoxycarbonylcyclopentanone with an alkaline reagent to form an intermediate, and then hydrolyzing under acidic conditions. 2-(4-(1-carboxyethyl)benzyl)adipic acid was obtained, and the basic reagent was added in batches to reduce the generation of by-products and improve the yield and purity of the target product.

Benefits of technology

The preparation of high-purity 2-(4-(1-carboxyethyl)benzyl)adipic acid was achieved, and it was used for the qualitative and quantitative analysis of loxoprofen sodium drugs, improving the drug safety and production quality of drugs control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019250A_ABST
    Figure CN119019250A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biological medicines, and particularly discloses 2-(4-(1-carboxyethyl) benzyl) adipic acid and a preparation method thereof. The structural formula of the 2-(4-(1-carboxyethyl) benzyl) adipic acid provided by the invention is as shown in formula I: # imgabs0. The invention also provides a preparation method and application of the 2-(4-(1-carboxyethyl) benzyl) adipic acid. The 2-(4-(1-carboxyethyl) benzyl) adipic acid provided by the invention can be used as a standard substance for qualitative and quantitative analysis of loxoprofen sodium bulk drugs and related preparation drug impurities, and realizes quality control of loxoprofen sodium and related preparation drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biomedicine technology, and in particular to 2-(4-(1-carboxyethyl)benzyl)adipic acid and a preparation method thereof. Background Art

[0002] Loxoprofen Sodium, whose chemical name is 2-[4-(2-oxocyclopentane-1-ylmethyl)phenyl]propionate sodium, is a white or yellowish white crystal or crystalline powder, which is easily soluble in water and methanol, slightly soluble in acetone, and almost insoluble in ether; the CAS number of Loxoprofen Sodium is 80382-23-6, and the molecular formula is as follows: Loxoprofen sodium is a non-steroidal anti-inflammatory analgesic and a prodrug. After being absorbed by the digestive tract, it can be converted into active metabolites, thereby exerting significant analgesic, anti-inflammatory and antipyretic effects. Studies have found that during the production process of loxoprofen sodium, an open-ring impurity 2-(4-(1-carboxyethyl)benzyl)adipic acid is produced. This impurity can affect the quality of the drug and produce side effects, thereby affecting the safety of drug use. Therefore, the study of the content of this impurity is the key to drug quality evaluation and control.

[0003] However, there is no report on the synthesis of 2-(4-(1-carboxyethyl)benzyl)adipic acid, an open-ring impurity of loxoprofen sodium. Therefore, there is an urgent need to provide a simple and efficient method for synthesizing 2-(4-(1-carboxyethyl)benzyl)adipic acid, so as to obtain high-purity 2-(4-(1-carboxyethyl)benzyl)adipic acid, so as to prepare impurity reference substances for qualitative and quantitative analysis of impurities in the production of loxoprofen sodium and its preparations, and to achieve quality evaluation and control of loxoprofen sodium drugs. Summary of the invention

[0004] In order to achieve qualitative and quantitative analysis of 2-(4-(1-carboxyethyl)benzyl)adipic acid, an impurity in loxoprofen sodium, the present application provides 2-(4-(1-carboxyethyl)benzyl)adipic acid and a preparation method thereof.

[0005] In the first aspect, the 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid provided by the present application adopts the following technical scheme: A 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid, wherein the structural formula of the 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is as shown in Formula I:

[0006] In a second aspect, the present application provides a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid.

[0007] A method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid comprises the following steps: (1) Under nitrogen protection, 2-methoxycarbonylcyclopentanone is dissolved in a solvent, and then part / all of the alkaline reagent I and methyl 2-[4-(bromomethyl)phenyl]propionate are added in sequence, and the reaction is stirred at 30-35° C. until the reaction of methyl 2-[4-(bromomethyl)phenyl]propionate is completed; then the remaining alkaline reagent I is added, and the temperature is raised to 40-120° C. and the tube is sealed and reacted for 12-24 hours, and the pH is adjusted to 7-8 with an acid, and the intermediate is obtained by distillation under reduced pressure and purification; wherein the molar ratio of 2-methoxycarbonylcyclopentanone to the alkaline reagent I is 1:(1.5-8), and the molar ratio of 2-methoxycarbonylcyclopentanone to methyl 2-[4-(bromomethyl)phenyl]propionate is 1:(0.7-0.9); (2) Then the intermediate is dissolved in a solvent, an alkaline reagent II is added, and the reaction is carried out at 25-100° C. for 3-5 hours. The pH is adjusted to 1-7 with an acid, and 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is obtained after extraction and concentration under reduced pressure; wherein the molar ratio of the intermediate to the alkaline reagent II is 1:(2-6).

[0008] The present application provides a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid. The preparation method has the advantages of simple operation, high yield and purity of 2-(4-(1-carboxyethyl)benzyl)adipic acid, etc. The 2-(4-(1-carboxyethyl)benzyl)adipic acid prepared by the method can be used for qualitative and quantitative analysis of impurities in loxoprofen sodium raw materials and related preparations, so as to strengthen the quality control of loxoprofen sodium and related preparations, thereby improving the product quality of loxoprofen sodium and related preparations.

[0009] In the preparation method of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid provided in the present application, 2-methoxycarbonylcyclopentanone is first used as a starting material, and reacts with methyl 2-[4-(bromomethyl)phenyl]propionate under the action of an alkaline reagent I to generate a dimethyl 2-[4-(1-methoxy-1-oxoprop-2-yl)phenyl]methyl)hexanedioate intermediate, and then the intermediate is hydrolyzed and ring-opened under the action of an alkaline reagent II to generate 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid. The synthetic route of the above reaction is as follows: Optionally, the alkaline reagent I is added in batches, and the alkaline reagent I is selected from one or more of sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide and sodium hydride.

[0010] In the present application, the alkaline reagent I can be added in batches; specifically, at the beginning of the reaction, the alkaline reagent I and 2-methoxycarbonylcyclopentanone are first added to the system in a molar ratio of 1:1 for low-temperature reaction, and then the remaining alkaline reagent I is added to the reaction system for high-temperature closed reaction. The above-mentioned alkaline reagent I is added in batches to effectively reduce the generation of by-products, increase the generation of the target intermediate, and thus improve the yield and purity of the final product 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid.

[0011] In some embodiments, the molar ratio of the 2-methoxycarbonylcyclopentanone to the alkaline reagent I can be 1:(1.5-2), 1:(1.5-4), 1:(1.5-6), 1:(1.5-8), 1:(2-4), 1:(2-6), 1:(2-8), 1:(4-6), 1:(4-8) or 1:(6-8).

[0012] In a specific embodiment, the molar ratio of the 2-methoxycarbonylcyclopentanone to the alkaline reagent I can also be 1:1.5, 1:2, 1:4, 1:6 or 1:8.

[0013] In some embodiments, the molar ratio of the intermediate to the alkaline reagent II can be 1:(2-3), 1:(2-4), 1:(2-5), 1:(2-6), 1:(3-4), 1:(3-5), 1:(3-6), 1:(4-5), 1:(4-6) or 1:(5-6).

[0014] In a specific embodiment, the molar ratio of the intermediate to the alkaline reagent II can also be 1:2, 1:3, 1:4, 1:5 or 1:6.

[0015] Optionally, the alkaline reagent I is selected from one or more of sodium methoxide, sodium ethoxide and sodium tert-butoxide.

[0016] Optionally, the molar ratio of the 2-methoxycarbonylcyclopentanone to the base is 1:(2-6).

[0017] Optionally, the alkaline reagent II is selected from one or more of lithium hydroxide, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate and DBU.

[0018] Optionally, the molar ratio of the intermediate to the alkaline reagent II is 1:(3-5).

[0019] Optionally, the solvent is selected from one or more of methanol, ethanol, toluene, dioxane, acetonitrile and water; the acid is one or more of acetic acid, formic acid, hydrochloric acid, sulfuric acid, phosphoric acid and citric acid; and the reagent used for extraction is dichloromethane.

[0020] Optionally, the reaction temperature of step (2) is 50-110°C, and the reaction temperature of step (3) is 50-90°C.

[0021] In a third aspect, the present application provides the use of 2-(4-(1-carboxyethyl)benzyl)adipic acid in the quality control of loxoprofen sodium and related preparations.

[0022] The 2-(4-(1-carboxyethyl)benzyl)adipic acid prepared in the present application can be used as an impurity standard for qualitative and quantitative analysis of impurities and scientific evaluation of the quality of loxoprofen sodium and preparations, thereby improving the safety of loxoprofen sodium and preparations.

[0023] In summary, this application has the following beneficial effects: 1. The preparation method of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid provided in the present application has the advantages of simple operation, high yield and purity of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid, etc. The 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid prepared by the method can be used as an impurity standard for qualitative and quantitative analysis of impurities, scientifically evaluating the quality of loxoprofen sodium and preparations, thereby improving the safety of loxoprofen sodium and preparations.

[0024] 2. The present application further controls the molar ratio of 2-methoxycarbonylcyclopentanone to alkaline reagent I within the range of 1:(2-6), and the molar ratio of the intermediate to alkaline reagent II within the range of 1:(3-5), and the yield and purity of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid are higher. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 This is the nuclear magnetic resonance spectrum of 2-(4-(1-carboxyethyl)benzyl)adipic acid obtained in Example 1. DETAILED DESCRIPTION

[0026] The present application provides a 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid compound, and a preparation method thereof comprises the following steps: (1) Under nitrogen protection, 2-methoxycarbonylcyclopentanone is dissolved in a solvent, and then part / all of the alkaline reagent I and methyl 2-[4-(bromomethyl)phenyl]propionate are added in sequence, and the reaction is stirred at 30-35° C. until the reaction of methyl 2-[4-(bromomethyl)phenyl]propionate is completed; then the remaining alkaline reagent I is added, and the temperature is raised to 40-120° C. and the tube is sealed for reaction for 12-24 hours, and the pH is adjusted to 7-8 with an acid, and the intermediate is obtained by distillation under reduced pressure and purification; wherein the molar ratio of 2-methoxycarbonylcyclopentanone to the alkaline reagent I is 1:(1.5-8), and the molar ratio of 2-methoxycarbonylcyclopentanone to methyl 2-[4-(bromomethyl)phenyl]propionate is 1:(0.7-0.9); further, the molar ratio of the 2-methoxycarbonylcyclopentanone to the base is 1:(2-6).

[0027] (2) Then the intermediate is dissolved in a solvent, an alkaline reagent II is added, and the reaction is carried out at 25-100° C. for 3-5 hours, and the pH is adjusted to 1-7 with an acid. After extraction and concentration under reduced pressure, 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is obtained; wherein the molar ratio of the intermediate to the alkaline reagent II is 1:(2-6); further, the molar ratio of the intermediate to the alkaline reagent II is 1:(3-5).

[0028] Furthermore, in step (1), the alkaline reagent I can be added in batches, that is, a portion is added during the low-temperature reaction at 30-35°C, and a portion is added during the high-temperature reaction at 40-120°C.

[0029] Wherein, the alkaline reagent I is selected from one or more of sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide and sodium hydride, and further, the alkaline reagent I is selected from one or more of sodium methoxide, sodium ethoxide and sodium tert-butoxide; the alkaline reagent II is selected from one or more of lithium hydroxide, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate and DBU; the solvent is selected from one or more of methanol, ethanol, toluene, dioxane, acetonitrile and water; the acid is one or more of acetic acid, formic acid, hydrochloric acid, sulfuric acid, phosphoric acid and citric acid; the reagent used for extraction is dichloromethane.

[0030] In the examples of the present application, the CAS number of 2-methoxycarbonylcyclopentanone is 10472-24-9; the CAS number of methyl 2-[4-(bromomethyl)phenyl]propionate is 99807-54-2; the remaining raw materials, reagents, solvents, etc. of the present application can also be obtained commercially.

[0031] The present application is further described in detail below in combination with preparation examples, embodiments and detection experiments.

[0032] Example 1 Embodiment 1 provides a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid, comprising the following steps: (1) Under nitrogen protection, 2-methoxycarbonylcyclopentanone (3.59 g, 25.26 mmol) was dissolved in toluene (50 mL), and sodium methoxide (1.36 g, 25.26 mmol) was added; then methyl 2-[4-(bromomethyl)phenyl]propionate (5.00 g, 19.45 mmol) was added, and the mixture was stirred at 35° C. for about 3 hours (the reaction of methyl 2-[4-(bromomethyl)phenyl]propionate was completed as monitored by TLC), and the mixture was distilled under reduced pressure to remove toluene; then methanol (50 mL) and sodium methoxide (4.09 g, 75.78 mmol) were added to the reaction system, and the temperature was raised to 100° C. and the tube was sealed for reaction for 12 hours. The pH was adjusted to 7.5 with acid, and the mixture was distilled under reduced pressure and column chromatography was performed with petroleum ether / ethyl acetate to obtain dimethyl 2-[4-(1-methoxy-1-oxopropan-2-yl)phenyl]methyl)adipate intermediate; (2) Then, the intermediate 2-[4-(1-methoxy-1-oxopropan-2-yl)phenyl]methyl)dimethyl adipate (1.00 g, 2.85 mmol) was dissolved in methanol / water (20 mL) with a volume ratio of 1:1, and sodium hydroxide (0.46 g, 11.50 mmol) was added. The mixture was reacted at 65° C. for 3 h, and the pH was adjusted to 4 with acid. The mixture was extracted with dichloromethane (20 mL×3 times), and the dichloromethane phases were combined and washed with saturated brine (50 mL×1 time). The dichloromethane phase was concentrated under reduced pressure to obtain 2-(4-(1-carboxyethyl)benzyl)adipate.

[0033] Embodiment 2-8 Examples 2-8 respectively provide a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid.

[0034] The difference between the above embodiment and embodiment 1 is that in the preparation method of 2-(4-(1-carboxyethyl)benzyl)adipic acid, the type and addition amount of the alkaline reagent I are specifically shown in Table 1 below.

[0035] Table 1 Type and amount of alkaline reagent I in the preparation methods of Example 1 and Examples 2-10 Example 9 Example 9 provides a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid.

[0036] The difference between the above embodiment and embodiment 1 is that step (1) is as follows: (1) Under nitrogen protection, 2-methoxycarbonylcyclopentanone (3.59 g, 25.26 mmol) was dissolved in methanol (50 mL), and sodium methoxide (5.46 g, 101.07 mmol) was added; then methyl 2-[4-(bromomethyl)phenyl]propanoate (5.00 g, 19.45 mmol) was added, and the mixture was stirred at 35° C. for about 3 hours (the reaction of methyl 2-[4-(bromomethyl)phenyl]propanoate was completed as monitored by TLC); then the temperature was raised to 100° C. and the tube was sealed for reaction for 12 hours, the pH was adjusted to 7.5 with acid, and the mixture was distilled under reduced pressure and column chromatography was performed with petroleum ether / ethyl acetate to obtain dimethyl 2-[4-(1-methoxy-1-oxopropan-2-yl)phenyl]methyl)adipate intermediate; Examples 10-13 Examples 10-13 respectively provide a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid.

[0037] The difference between the above embodiment and embodiment 1 is that the amount of alkaline reagent II (sodium hydroxide) added is as shown in Table 2 below.

[0038] Table 2 The amount of sodium hydroxide added in Example 1 and Examples 10-13 Embodiment 14 Example 14 provides a method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid.

[0039] The difference between the above embodiment and embodiment 1 is that the alkaline reagent II (sodium hydroxide) is replaced by lithium hydroxide.

[0040] Performance testing (1) The nuclear magnetic resonance (NMR) spectrum of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid obtained in Example 1 was measured using a 400 MHz nuclear magnetic resonance spectrometer. The spectrum is shown in FIG. Figure 1 The specific results are as follows: MS (ESI) [MH]-=307; HNMR (400 MHz, CD3Cl, ppm) δ12.08 (s, 3H), 7.12-7.19 (m, 4H), 3.59-3.65 (m, 1H), 2.64-2.81 (m, 2H), 2.55 (s, 1H), 2.17-2.22 (m, 2H), 1.54 (t, J=13.2 Hz, 4H), 1.30 (m, 3H).

[0041] (2) According to the methods of Examples 1-14, 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid was prepared respectively, the total yield (the product of the two-step reaction yields) was calculated, and the purity of the final product 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid was tested. The results are shown in Table 3 below.

[0042] Table 3 Total yield and purity of 2-(4-(1-carboxyethyl)benzyl)adipic acid obtained in Examples 1-14 According to the test results of Table 3, the total yield of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid obtained by the preparation method provided in Examples 1-14 is 78.8-85.6%, and the purity is 98.25-99.30%. Therefore, it is explained that the preparation method of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid provided in Examples 1-14 of the present application can obtain 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid with high yield and high purity.

[0043] The test results of Example 1 and Example 9 show that Example 1 uses sodium methoxide as the alkaline reagent I in step (1), and adds it to the system in two batches, and the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 85.2% and the purity is 99.3%; while Example 9 uses sodium methoxide as the alkaline reagent I in step (1), and adds it directly to the system once, and the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is only 78.8% and the purity is 98.25%. Therefore, it is explained that in the preparation method of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid provided by the present application, the total yield and purity of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid can be significantly improved by adopting the method of adding in two batches.

[0044] The test results of Examples 1-8 show that in Example 1-5, sodium methoxide is used as the alkaline reagent I in step (1), and the molar ratio of 2-methoxycarbonylcyclopentanone to sodium methoxide is controlled within the range of 1:(1.5-8), and the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 81.2-85.2% and the purity is 98.64-99.30%; in Example 6, sodium methoxide is used as the alkaline reagent I added for the first time in step (1), and sodium ethoxide is used as the alkaline reagent I added for the second time in step (1), and the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 81.2-85.2% and the purity is 98.64-99.30%. The total yield of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 83.7% and the purity is 98.99%; in Example 7, sodium ethoxide is used as the alkaline reagent I in step (1), and the total yield of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 84.9% and the purity is 98.78%; in Example 8, sodium methoxide is used as the alkaline reagent I added for the first time in step (1) and sodium tert-butoxide is used as the alkaline reagent I added for the second time in step (1), and the total yield of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 83.1% and the purity is 98.43%. Therefore, it is explained that in the preparation method of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid provided in the present application, by using sodium methoxide, sodium ethoxide or sodium tert-butoxide as the alkaline reagent I in step (1), and adopting a two-batch addition method, 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid with a total yield of ≥80% and a purity of ≥98% can be obtained.

[0045] It can be seen from the test results of Examples 1-5 that with the increase in the amount of alkaline reagent I added, the yield and purity of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid both show a trend of first increasing and then decreasing. Among them, in Examples 1 and 3-4, the molar ratio of 2-methoxycarbonylcyclopentanone to alkaline reagent I is controlled within the range of 1:(2-6), and the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 83.3-85.2% (>83%) and the purity is 99.04-99.30% (>99.0%). Therefore, it is explained that the present application further controls the molar ratio of 2-methoxycarbonylcyclopentanone to alkaline reagent I within the range of 1:(2-6), and the yield and purity of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid are higher.

[0046] The test results of Example 1 and Examples 10-13 show that with the increase in the amount of alkaline reagent II added, the yield and purity of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid both show a trend of first increasing and then decreasing; when the molar ratio of the intermediate to sodium hydroxide in Example 10 is controlled to 1:2, the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 82.4% and the purity is 98.90%; when the molar ratio of the intermediate to sodium hydroxide in Example 13 is controlled to 1:2, the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 82.4% and the purity is 98.90%. When the molar ratio of the intermediate to sodium hydroxide is controlled to 1:6, the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 82.3% and the purity is 98.92%; when the molar ratio of the intermediate to sodium hydroxide is controlled to 1:(3-5) in Example 1 and Example 11-12, the total yield of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is 84.3-85.6% (>84%) and the purity is 99.14-99.30% (>99.0%). Therefore, it is explained that the present application further controls the molar ratio of the intermediate to the alkaline reagent II to be within the range of 1:(3-5), and the yield and purity of the obtained 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid are higher.

[0047] The test results of Example 1 and Example 14 show that Example 1 and Example 14 can both produce high-yield, high-purity 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid by using sodium hydroxide or lithium hydroxide as the alkaline reagent II in step (2); wherein, by using sodium hydroxide as the alkaline reagent II in step (2), the yield of the produced 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is higher.

[0048] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made thereto based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.

Claims

1. A 2-(4-(1-carboxyethyl)benzyl)adipic acid, characterized in that The structural formula of 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is shown in Formula I:

2. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 1, characterized in that: The following steps are involved: (1) Under nitrogen protection, 2-methoxycarbonylcyclopentanone is dissolved in a solvent, and then part / all of the alkaline reagent I and methyl 2-[4-(bromomethyl)phenyl]propionate are added in sequence, and the reaction is stirred at 30-35° C. until the reaction of methyl 2-[4-(bromomethyl)phenyl]propionate is completed; then the remaining alkaline reagent I is added, and the temperature is raised to 40-120° C. and the tube is sealed and reacted for 12-24 hours, and the pH is adjusted to 7-8 with an acid, and the intermediate is obtained by distillation under reduced pressure and purification; wherein the molar ratio of 2-methoxycarbonylcyclopentanone to the alkaline reagent I is 1:(1.5-8), and the molar ratio of 2-methoxycarbonylcyclopentanone to methyl 2-[4-(bromomethyl)phenyl]propionate is 1:(0.7-0.9); (2) Then the intermediate is dissolved in a solvent, an alkaline reagent II is added, and the reaction is carried out at 25-100° C. for 3-5 hours. The pH is adjusted to 1-7 with an acid, and 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid is obtained after extraction and concentration under reduced pressure; wherein the molar ratio of the intermediate to the alkaline reagent II is 1:(2-6).

3. The method for preparing 2-(4-(1-carboxyethyl)benzyl)hexanedioic acid according to claim 2, characterized in that: The alkaline reagent I is added in batches, and the alkaline reagent I is selected from one or more of sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide and sodium hydride.

4. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 2, characterized in that: The alkaline reagent I is selected from one or more of sodium methoxide, sodium ethoxide and sodium tert-butoxide.

5. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 2, characterized in that: The alkaline reagent II is selected from one or more of lithium hydroxide, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate and DBU.

6. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 2, characterized in that: The molar ratio of the 2-methoxycarbonylcyclopentanone to the alkaline reagent I is 1:(2-6).

7. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 2, characterized in that: The molar ratio of the intermediate to the alkaline reagent II is 1:(3-5).

8. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 2, characterized in that: The solvent is selected from one or more of methanol, ethanol, toluene, dioxane, acetonitrile and water; the acid is selected from one or more of acetic acid, formic acid, hydrochloric acid, sulfuric acid, phosphoric acid and citric acid; and the extraction reagent is dichloromethane.

9. The method for preparing 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 2, characterized in that: The temperature of the tube sealing reaction in step (1) is 50-110°C, and the reaction temperature of step (2) is 50-90°C.

10. Use of 2-(4-(1-carboxyethyl)benzyl)adipic acid obtained by the preparation method of 2-(4-(1-carboxyethyl)benzyl)adipic acid according to claim 1 or claims 2 to 9 in the quality control of loxoprofen sodium and related preparations.